New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
06:53 EDTFRXForest Labs acquisition positive, says Cantor
After Forest Labs agreed to buy Aptalis, a privately held company that focuses on gastrointestinal disease and cystic fibrosis, Cantor thinks that Aptalis is a good strategic fit for Forest Labs. The firm sees opportunities for revenue and cost synergies from the deal, and it raised its price target on Forest to $90 from $79 while keeping a Buy rating on the stock.
News For FRX From The Last 14 Days
Check below for free stories on FRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
17:32 EDTFRXIcahn Associates gives quarterly update on stakes
NEW STAKES: Gannett (GCI). INCREASED STAKES: Navistar (NAV), eBay (EBAY), and Icahn Enterprises (IEP). DECREASED STAKES: Netflix (NFLX). LIQUIDATED STAKES: Forest Laboratories (FRX).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use